The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection
dc.contributor.author | Dieudé, Mélanie | |
dc.contributor.author | Bell, Christina | |
dc.contributor.author | Turgeon, Julie | |
dc.contributor.author | Beillevaire, Déborah | |
dc.contributor.author | Yang, Bing | |
dc.contributor.author | Hamelin, Katia | |
dc.contributor.author | Qi, Shijie | |
dc.contributor.author | Pallet, Nicolas | |
dc.contributor.author | Béland, Chanel | |
dc.contributor.author | Dhahri, Wahiba | |
dc.contributor.author | Cailhier, Jean-François | |
dc.contributor.author | Rousseau, Matthieu | |
dc.contributor.author | Duchez, Anne-Claire | |
dc.contributor.author | Lévesque, Tania | |
dc.contributor.author | Lau, Arthur | |
dc.contributor.author | Rondeau, Christiane | |
dc.contributor.author | Gingras, Diane | |
dc.contributor.author | Muruve, Danie | |
dc.contributor.author | Rivard, Alain | |
dc.contributor.author | Cardinal, Héloïse | |
dc.contributor.author | Perreault, Claude | |
dc.contributor.author | Desjardins, Michel | |
dc.contributor.author | Boilard, Éric | |
dc.contributor.author | Thibault, Pierre | |
dc.contributor.author | Hébert, Marie-Josée | |
dc.date.accessioned | 2019-11-20T19:09:59Z | |
dc.date.available | NO_RESTRICTION | fr |
dc.date.available | 2019-11-20T19:09:59Z | |
dc.date.issued | 2015-12-16 | |
dc.identifier.uri | http://hdl.handle.net/1866/22562 | |
dc.publisher | American Association for the Advancement of Science | fr |
dc.title | The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de médecine | fr |
dc.identifier.doi | 10.1126/scitranslmed.aac9816 | |
dcterms.abstract | Autoantibodies to components of apoptotic cells, such as anti-perlecan antibodies, contribute to rejection in organ transplant recipients. However, mechanisms of immunization to apoptotic components remain largely uncharacterized. We used large-scale proteomics, with validation by electron microscopy and biochemical methods, to compare the protein profiles of apoptotic bodies and apoptotic exosome-like vesicles, smaller extracellular vesicles released by endothelial cells downstream of caspase-3 activation. We identified apoptotic exosome-like vesicles as a central trigger for production of anti-perlecan antibodies and acceleration of rejection. Unlike apoptotic bodies, apoptotic exosome-like vesicles triggered the production of anti-perlecan antibodies in naïve mice and enhanced anti-perlecan antibody production and allograft inflammation in mice transplanted with an MHC (major histocompatibility complex)–incompatible aortic graft. The 20S proteasome core was active within apoptotic exosome-like vesicles and controlled their immunogenic activity. Finally, we showed that proteasome activity in circulating exosome-like vesicles increased after vascular injury in mice. These findings open new avenues for predicting and controlling maladaptive humoral responses to apoptotic cell components that enhance the risk of rejection after transplantation. | fr |
dcterms.isPartOf | urn:ISSN:1946-6234 | fr |
dcterms.isPartOf | urn:ISSN:1946-6242 | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | PMID: 26676607 DOI: 10.1126/scitranslmed.aac9816 | fr |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | fr |
oaire.citationTitle | Science translational medicine | |
oaire.citationVolume | 7 | |
oaire.citationIssue | 318 |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.